Hypoestenonol B - Compound Card

Hypoestenonol B

Select a section from the left sidebar

Hypoestenonol B

Structure
Zoomed Structure
  • Family: Plantae - Acanthaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Fusicoccane Diterpene
Canonical Smiles CC(=O)O[C@H]1C[C@@]([C@@H]2[C@]1(C)CC1=C(C)C(=O)C[C@H]1C(=CC2)C)(O)C(C)C
InChI InChI=1S/C22H32O4/c1-12(2)22(25)11-20(26-15(5)23)21(6)10-17-14(4)18(24)9-16(17)13(3)7-8-19(21)22/h7,12,16,19-20,25H,8-11H2,1-6H3/t16-,19-,20-,21-,22+/m0/s1
InChIKey YDMMAWOPEAEISR-ADNIJMRFSA-N
Formula C22H32O4
HBA 4
HBD 1
MW 360.49
Rotatable Bonds 2
TPSA 63.6
LogP 3.98
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 26
Formal Charge 0
Fraction CSP3 0.73
Exact Mass 360.23
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Hypoestes foskalii Acanthaceae Plantae 13570

Showing of synonyms

  • Al Musayeib NM, Mothana RA, et al. (2014). Hypoestenonols A and B, new fusicoccane diterpenes from Hypoestes forskalei. Phytochemistry Letters,2014,10,23-27. [View]
Pubchem: 162817627

No compound-protein relationship available.

Structure

SMILES: C1C(=O)CC(C=12)C=CCC3C(C2)CCC3

Level: 0

Mol. Weight: 360.49 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.56
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.6
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.61

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.89
Plasma Protein Binding
72.95
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
12.87
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.01
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.28
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
6.03
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-2.78
Rat (Acute)
3.16
Rat (Chronic Oral)
1.79
Fathead Minnow
3.92
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
393.98
Hydration Free Energy
-6.15
Log(D) at pH=7.4
2.89
Log(P)
3.93
Log S
-4.3
Log(Vapor Pressure)
-6.25
Melting Point
156.99
pKa Acid
8.81
pKa Basic
3.91

No predicted protein targets found for this compound.

Download SDF